N-Methyl-PPPA
http://dbpedia.org/resource/N-Methyl-PPPA an entity of type: Thing
N-Methyl-PPPA, or N-methyl-3-phenoxy-3-phenylpropan-1-amine, is a serotonin-norepinephrine reuptake inhibitor (SNRI) which was developed by Eli Lilly from diphenhydramine in the early 1970s while in search of new antidepressants, but was never marketed. It is closely related structurally to fluoxetine, atomoxetine, and nisoxetine.
rdf:langString
rdf:langString
N-Methyl-PPPA
rdf:langString
N-Methyl-PPPA
xsd:integer
44997677
xsd:integer
1123080686
rdf:langString
None
xsd:integer
16
xsd:integer
16340904
rdf:langString
N-Methyl-PPPA
xsd:integer
19
rdf:langString
N-Methyl-3-phenoxy-3-phenyl-1-propanamine
xsd:integer
1
xsd:integer
1
rdf:langString
CNCCCc2ccccc2
xsd:integer
1
rdf:langString
DMOUAPYFRKLFHO-UHFFFAOYSA-N
rdf:langString
Detrifluoromethylfluoxetine
rdf:langString
N-Methyl-PPPA, or N-methyl-3-phenoxy-3-phenylpropan-1-amine, is a serotonin-norepinephrine reuptake inhibitor (SNRI) which was developed by Eli Lilly from diphenhydramine in the early 1970s while in search of new antidepressants, but was never marketed. It is closely related structurally to fluoxetine, atomoxetine, and nisoxetine.
xsd:nonNegativeInteger
3009